IL94183A - cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE - Google Patents

cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE

Info

Publication number
IL94183A
IL94183A IL9418390A IL9418390A IL94183A IL 94183 A IL94183 A IL 94183A IL 9418390 A IL9418390 A IL 9418390A IL 9418390 A IL9418390 A IL 9418390A IL 94183 A IL94183 A IL 94183A
Authority
IL
Israel
Prior art keywords
lactoferrin protein
lactoferrin
cdna
sequence
protein
Prior art date
Application number
IL9418390A
Other languages
English (en)
Other versions
IL94183A0 (en
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23367308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL94183(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of IL94183A0 publication Critical patent/IL94183A0/xx
Publication of IL94183A publication Critical patent/IL94183A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL9418390A 1989-05-05 1990-04-24 cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE IL94183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34827089A 1989-05-05 1989-05-05

Publications (2)

Publication Number Publication Date
IL94183A0 IL94183A0 (en) 1991-01-31
IL94183A true IL94183A (en) 2003-09-17

Family

ID=23367308

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9418390A IL94183A (en) 1989-05-05 1990-04-24 cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE

Country Status (13)

Country Link
US (3) US6228614B1 (fr)
EP (1) EP0471011B2 (fr)
JP (1) JP2701976B2 (fr)
AT (1) ATE112801T1 (fr)
AU (1) AU5661890A (fr)
CA (1) CA2015994C (fr)
DE (1) DE69013342T3 (fr)
DK (1) DK0471011T4 (fr)
ES (1) ES2061038T5 (fr)
IE (1) IE66820B1 (fr)
IL (1) IL94183A (fr)
NZ (1) NZ233450A (fr)
WO (1) WO1990013642A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
IL94183A (en) 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DK0510912T3 (da) * 1991-04-24 1998-02-09 Morinaga Milk Industry Co Ltd Antimikrobielt peptid og antimikrobielt middel
CA2110404A1 (fr) * 1991-05-31 1992-12-10 Christina Teng Lactoferrine humaine
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
JP3529423B2 (ja) * 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
WO1995030339A1 (fr) * 1994-05-05 1995-11-16 Ferrodynamics, Inc. Clonage, expression et utilisations de la lactoferrine humaine
FR2735983B1 (fr) 1995-06-29 1997-12-05 Centre Nat Rech Scient Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
ES2212357T3 (es) * 1997-09-16 2004-07-16 Wolf-Georg Forssmann Peptidos bifidogenos y su uso.
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
AU2229901A (en) * 1999-12-28 2001-07-09 Sumitomo Pharmaceuticals Company, Limited Preventives and remedies for chronic hepatitis
WO2003057712A2 (fr) * 2001-12-28 2003-07-17 Campina B.V. Lactoferrine humanisee et utilisations de celle-ci
ATE519499T1 (de) * 2002-05-10 2011-08-15 Agennix Inc Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
SI2298338T1 (sl) 2002-09-16 2012-11-30 Agennix Inc Laktoferinski sestavki in postopki za zdravljenjekožnih ran
JP4795021B2 (ja) * 2002-12-06 2011-10-19 エイジェニックス インコーポレイテッド 敗血症治療における経口用ラクトフェリン
US7592306B2 (en) * 2002-12-10 2009-09-22 Agennix, Inc. Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
WO2004103285A2 (fr) * 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrine pour traitement du diabete sucre
WO2005046571A2 (fr) * 2003-06-06 2005-05-26 Agennix Incorporated Lactoferrine en tant qu'adjuvant de vaccins contre le cancer
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
WO2006047744A2 (fr) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions de peptides en rapport avec la lactoferrine et utilisations
WO2006074450A2 (fr) * 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methodes et compositions permettant de detecter et de moduler les maladies et les troubles parodontaux
US20090149166A1 (en) * 2006-04-24 2009-06-11 Hakem Mohamedali Habib Method, system and apparatus for conveying an event reminder
NZ555163A (en) 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
US20130034542A1 (en) * 2010-04-23 2013-02-07 Probiotec Limited Cold treatment
RU2554742C1 (ru) * 2013-12-26 2015-06-27 Российская Федерация, от имени которой выступает Министерство образования и науки РФ Технология опытного выделения лактоферрина человека
HUE037916T2 (hu) * 2015-11-20 2018-09-28 Geroa Diagnostics S L Laktoferrin Alzheimer-kór diagnózisában és prognózisában történõ alkalmazására
TWI614022B (zh) * 2016-02-23 2018-02-11 肌活麗學創研所股份有限公司 降低黑色素含量的胜肽、方法及組合物

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US190303A (en) * 1877-05-01 Improvement in ticket-punches
US82504A (en) * 1868-09-29 Improvement in mitre-machines
US9896A (en) * 1853-08-02 Abdominal suppobtek
US9895A (en) * 1853-08-02 Apparatus to regrulate the supply of water
US142037A (en) * 1873-08-19 Improvement in match-planes
US75277A (en) * 1868-03-10 Improvement in deiees
US105006A (en) * 1870-07-05 Improvement in cotton-seed planters
US733621A (en) * 1902-07-07 1903-07-14 W G Browne Mfg Company Egg-beater.
US728521A (en) * 1902-08-05 1903-05-19 Edward Turney Clutch-operating mechanism.
US732429A (en) * 1902-10-06 1903-06-30 Charles E Napp Holder for directory-leaves, &c.
US728275A (en) * 1902-12-08 1903-05-19 Jesse Morgenthau Coin-operated weighing-machine.
US862213A (en) * 1905-10-09 1907-08-06 David J Strassel Ribbon-slide.
US844865A (en) * 1906-08-24 1907-02-19 William J M Hames Polisher and cleaner.
IN150740B (fr) 1978-11-24 1982-12-04 Hoffmann La Roche
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4394443A (en) 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4652639A (en) 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
JPS6016669A (ja) 1983-07-08 1985-01-28 石川島播磨重工業株式会社 浮基礎式貯槽の底板の建設方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4740461A (en) 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4710465A (en) 1984-04-19 1987-12-01 Yale University Junction-fragment DNA probes and probe clusters
LU85479A1 (fr) 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
JPS61145200A (ja) 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
US4886747A (en) 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
EP0206783A3 (fr) 1985-06-20 1988-10-05 The Salk Institute Biotechnology Industrial Associates, Inc. Expression et secrétion de polypeptides à partir de Saccharomyces cerevisiae
US4959318A (en) 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
FR2600250B1 (fr) 1986-06-23 1989-11-24 Bio Serae Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
US4965190A (en) 1986-07-31 1990-10-23 Howard Hughes Medical Institute Methods for the identification of mutations in the human phenylalanine hydroxylase gene using DNA probes
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5019508A (en) 1987-08-27 1991-05-28 Biotechnology Research Partners, Ltd. Synovial phospholipases
JP2703598B2 (ja) 1987-09-04 1998-01-26 ノボ―ノルディスク アクティーゼルスカブ アスペルギルス菌中でのタンパク質生産物の生産方法およびアスペルギルス菌中で使用するためのプロモーター
US5081227A (en) 1988-03-04 1992-01-14 La Jolla Cancer Research Foundation Germ cell alkaline phosphatase
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
US5571691A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
US6100054A (en) * 1989-05-05 2000-08-08 Baylor College Of Medicine Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
US5849881A (en) * 1989-05-05 1998-12-15 Baylor College Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
US5766939A (en) * 1989-05-05 1998-06-16 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
US5155037A (en) 1989-08-04 1992-10-13 The Texas A&M University System Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems
AU6406590A (en) 1989-09-28 1991-04-28 Granada Biosciences, Inc. Porcine lactoferrin amino acid and cdna sequence
EP0737746A3 (fr) 1989-12-01 1996-10-23 Pharming B.V. Production de polypeptides recombinants par l'espèce bovine et procédés transgéniques
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
AU7453391A (en) 1990-03-08 1991-10-10 Ferrodynamics, Inc. Genetically engineered human lactoferrin
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
US5166145A (en) 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
NZ245713A (en) 1992-02-10 1994-12-22 Novopharm Ltd Production of the antibiotic lovastatin from genetically engineered aspergillus strains
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
JP3557011B2 (ja) * 1995-03-30 2004-08-25 株式会社東芝 半導体発光素子、及びその製造方法
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide

Also Published As

Publication number Publication date
IE901483L (en) 1990-11-05
ES2061038T3 (es) 1994-12-01
DK0471011T3 (da) 1994-11-14
US6635447B1 (en) 2003-10-21
EP0471011A1 (fr) 1992-02-19
CA2015994C (fr) 2000-02-15
JPH04505101A (ja) 1992-09-10
DE69013342D1 (de) 1994-11-17
DK0471011T4 (da) 2004-09-13
AU5661890A (en) 1990-11-29
DE69013342T2 (de) 1995-03-23
US20050064546A1 (en) 2005-03-24
ES2061038T5 (es) 2005-03-16
EP0471011B1 (fr) 1994-10-12
WO1990013642A1 (fr) 1990-11-15
US6228614B1 (en) 2001-05-08
ATE112801T1 (de) 1994-10-15
IL94183A0 (en) 1991-01-31
EP0471011B2 (fr) 2004-08-18
NZ233450A (en) 1992-10-28
CA2015994A1 (fr) 1990-11-05
DE69013342T3 (de) 2005-02-17
IE66820B1 (en) 1996-02-07
JP2701976B2 (ja) 1998-01-21

Similar Documents

Publication Publication Date Title
IL94183A (en) cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
KR100221404B1 (en) Production of recombinant human lactoferrin
IL71615A0 (en) Secretion of exogenous polypeptides from yeast
IL102783A0 (en) Dna sequence encoding bovine alpha-lactalbumin and methods of use
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
IL112402A (en) Methods for producing N-alanyl porcine somatotropin and compositions thereof
ES8506347A1 (es) Un metodo para producir un polipeptido de tipo il-2-".
HU911994D0 (en) New signal sequences
ATE113074T1 (de) Neue aprotinin-varianten und gentechnisches verfahren zur mikrobiellen herstellung dieser varianten in homogen prozessierter form.
EP0723016A3 (fr) Facteur d'activation des leukocytes
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
EP0832972A3 (fr) Expression de peptides utilisés comme exhausteurs de gout

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired